MAG
HCAT icon

Millrace Asset Group’s Health Catalyst HCAT Stock Holding History

Millrace Asset Group’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.57M Buy
+192,616
New +$1.39M 1.59% 28

Other funds holding HCAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Millrace Asset Group's HCAT Position: Q3 2024 in Review

Millrace Asset Group opened a new position in Health Catalyst (HCAT) in Q3 2024: 192,616 shares worth $1.57M. The stake represents 1.59% of the portfolio and ranks #28 among its holdings.

159 funds tracked by Wall St. Rank hold HCAT as of Q3 2024.

  • Millrace Asset Group held 192,616 shares of Health Catalyst worth $1.57M as of Q3 2024.
  • Health Catalyst was a new Millrace Asset Group position in Q3 2024.
  • Health Catalyst made up 1.59% of Millrace Asset Group's portfolio in Q3 2024, its #28 holding.
  • 159 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2024.

Based on Millrace Asset Group's 13F filing for Q3 2024, filed 13 Nov 2024.